Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Moehs Iberica SL
02 1Aurobindo Pharma Limited
03 4Catalent Micron Technologies Ltd
04 1ESCIENTIA ADVANCED SCIENCES PRIVATE LIMITED
05 1MSN Life Sciences Private Limited
06 1Procos S.p.A.
01 1RIMEGEPANT SULFATE
02 5Rimegepant
03 1Rimegepant Hemisulfate Sesquihydrate
04 2Rimegepant Sulfate
01 2India
02 1Italy
03 1Spain
04 4U.S.A
05 1Blank
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 81912-0002
Start Marketing Date : 2023-09-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-884
Start Marketing Date : 2024-01-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69989-0009
Start Marketing Date : 2019-09-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 69989-0010
Start Marketing Date : 2019-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 69989-0012
Start Marketing Date : 2021-08-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 69989-0013
Start Marketing Date : 2020-10-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 69766-112
Start Marketing Date : 2023-09-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46016-1370
Start Marketing Date : 2017-07-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72804-0004
Start Marketing Date : 2023-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Rimegepant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rimegepant, including repackagers and relabelers. The FDA regulates Rimegepant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rimegepant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rimegepant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rimegepant supplier is an individual or a company that provides Rimegepant active pharmaceutical ingredient (API) or Rimegepant finished formulations upon request. The Rimegepant suppliers may include Rimegepant API manufacturers, exporters, distributors and traders.
click here to find a list of Rimegepant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rimegepant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rimegepant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rimegepant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rimegepant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rimegepant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rimegepant suppliers with NDC on PharmaCompass.
We have 5 companies offering Rimegepant
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
